2003

“EVENTS” 3D text surrounded by calendar dates. Part of a series.

  • December 2003 – Publication with the Early Detection Research Network, “Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer”, W.E. Grizzle, B.L. Adam, W.L. Bigbee, T.P. Conrads, C. Carroll, Z. Feng, M. Jendoubi, et al. (2003-2004), Dis Marker 19(4-5):185-195
  • October 2003 –AACR Frontiers in Cancer Prevention Research, October 26-30, 2003, Phoenix, AZ, “Candidate Secreted Biomarkers in Plasma for the Early Detection of Stage I Lung Cancer” C. Chavany, S. Chen, K. Yamaguchi, S. Schramm, M. Jendoubi, S. Zafar*, A. Greenberg*, B. Crawford*, M. Zervos*, W.N. Rom*, * NYU School of Medicine, Poster Presentation, Dr. Christine Chavany
  • October 2003 –AACR Frontiers in Cancer Prevention Research, October 26-30, 2003, Phoenix, AZ, “Metastatic versus Non-metastatic Serum Markers in Melanoma” C. Chavany, S. Chen, K. Yamaguchi, S. Schramm, M. Jendoubi, L. Shaik*, M. Kashani-Sabet*, *UCSF Melanoma Center, Poster Presentation, Dr. Moncef Jendoubi
  • October 2003 –AACR Frontiers in Cancer Prevention Research, October 26-30, 2003, Phoenix, AZ, “Identification of Distinct Secreted Biomarkers in Serum for Ovarian Cancer Stages I-IV” S. Chen, C. Chavany, K. Yamaguchi, S. Schramm, M. Jendoubi, Poster Presentation, Steven Chen
  • September 2003 – Milagen is awarded Phase I Small Business Innovation Research Contract (SBIR) sponsored by the National Cancer Institute (NCI) on “High-Throughput Protein Profiling in Mouse Models of Cancer”
  • July 2003 – 94th Annual Meeting, American Association for Cancer Research, July 11-14, 2003, Washington, DC, “Antibody-based Approach to Biomarker Discovery: Identification of Stage Specific Antibodies and Protein Targets in Breast Cancer” C. Chavany, M. Jendoubi, Poster Presentation, Dr. Christine Chavany
  • March 2003 – Proteomics: Technologies and Applications, Keystone Symposium 2003, March 25-30, Keystone, CO, “Large-scale Functional Approach of Proteins in Human Diseases” C. Chavany, M. Jendoubi
  • March 2003 – Molecular Targets for Cancer therapy, Keystone Symposium 2003, March 19-24, 2003, Banff, Alberta, Canada, “Unique Antibody-based Approach to Target Discovery in Cancer: Application to the Identification of Protein Targets in Breast Cancer” C. Chavany, M. Jendoubi, Poster Presentation, Dr. Moncef Jendoubi
  • March 2003 – “Antibody-based technologies for target discovery” R.P.C. Valle, M. Jendoubi, Current Opinion in Drug Discovery & Development, 6(2):197-203
  • February 2003 – Technological Advances in Cancer Research, IBC Lifesciences, February 10-12, 2003, Bethesda, MD, “Multiplexed Antibody-Base Approach for Target Discovery and Diagnostic Applications in Cancer,” Invited Speaker, Dr. Moncef Jendoubi
  • February 2003 – Antibody Therapeutics in Cancer, Keystone Symposium 2003, February 4-9, 2003, Banff, Alberta, Canada “AntibiomixTM: A Unique Antibody-Based Approach for Target Discovery” C. Chavany, S. Chen, Y. Xu, E.Q. Fernandez, R.P.C. Valle, M. Jendoubi, Poster Presentation, Dr. Christine Chavany
  • January 2003 – “New approaches for biomarker discovery in lung cancer” R.P.C. Valle, C. Chavany, T.A. Zhukov, M. Jendoubi, Expert Review of Molecular Diagnostics 3(1):55-67